Nearly Four Million Medicare Beneficiaries Could Be Eligible for the Temporary Medicare GLP-1 Bridge Program Covering These Drugs for Weight Loss

This news release highlights that a KFF analysis finds that 3.8 million Medicare beneficiaries met the criteria to be eligible for the new Medicare GLP-1 Bridge, based on claims data from 2023. The temporary program will provide coverage of three GLP-1 drugs used for weight reduction and weight management to eligible Medicare beneficiaries.

Read More

Novo Nordisk Adds to Manufacturing Capacity, Pumping Billions Into New Rare Disease Site

Novo Nordisk’s new Denmark site will produce drugs for rare diseases, such as hemophilias. Separately, the pharma giant said all regulatory conditions have been met for Novo Holdings’ acquisition of Catalent, which will bring to Novo Nordisk three manufacturing sites for GLP-1 medications. The post Novo Nordisk Adds to Manufacturing Capacity, Pumping Billions Into New…

Read More

Hinge Health Launches MSK Collaboration with Cigna Healthcare

Cigna’s self-insured clients now have the option to offer the Hinge Health platform to its employees. Through the platform, patients gain virtual access to physical therapists, health coaches, real-time guidance and a wearable pain relief device. The post Hinge Health Launches MSK Collaboration with Cigna Healthcare appeared first on MedCity News.

Read More